Global Short Bowel Syndrome Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Short Bowel Syndrome Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Oral Short Bowel Syndrome Drugs
1.2.3 Tablet Short Bowel Syndrome Drugs
1.3 Market Segment by Sale Channel
1.3.1 Global Short Bowel Syndrome Drugs Market Share by Sale Channel (2017 VS 2021 VS 2028)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Short Bowel Syndrome Drugs Market Size (2017-2028)
2.1.1 Global Short Bowel Syndrome Drugs Revenue (2017-2028)
2.1.2 Global Short Bowel Syndrome Drugs Sales (2017-2028)
2.2 Global Short Bowel Syndrome Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Short Bowel Syndrome Drugs Sales by Regions (2017-2022)
2.2.2 Global Short Bowel Syndrome Drugs Revenue by Regions (2017-2022)
2.3 Global Short Bowel Syndrome Drugs Market Size Forecast by Region
2.3.1 Global Short Bowel Syndrome Drugs Sales Forecast by Region (2023-2028)
2.3.2 Global Short Bowel Syndrome Drugs Revenue Forecast by Region (2023-2028)
2.4 Global Top Short Bowel Syndrome Drugs Regions (Countries) Ranking by Market Size
2.5 Short Bowel Syndrome Drugs Market Dynamics
2.5.1 Short Bowel Syndrome Drugs Market Trends
2.5.2 Short Bowel Syndrome Drugs Market Drivers
2.5.3 Short Bowel Syndrome Drugs Market Challenges
2.5.4 Short Bowel Syndrome Drugs Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Short Bowel Syndrome Drugs Manufacturers by Sales (2017-2022)
3.1.1 Global Short Bowel Syndrome Drugs Sales by Manufacturers (2017-2022)
3.1.2 Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Short Bowel Syndrome Drugs Sales in 2021
3.2 Global Top Manufacturers Short Bowel Syndrome Drugs by Revenue
3.2.1 Global Short Bowel Syndrome Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Top Short Bowel Syndrome Drugs Manufacturers Covered: Ranking by Revenue
3.2.3 Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Short Bowel Syndrome Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Short Bowel Syndrome Drugs as of 2021)
3.4 Global Short Bowel Syndrome Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Short Bowel Syndrome Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Short Bowel Syndrome Drugs Market
3.7 Key Manufacturers Short Bowel Syndrome Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Short Bowel Syndrome Drugs Market Size by Type
4.1 Global Short Bowel Syndrome Drugs Historic Market Review by Type (2017-2022)
4.1.1 Global Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2022)
4.1.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2017-2022)
4.1.3 Short Bowel Syndrome Drugs Price by Type (2017-2022)
4.2 Global Short Bowel Syndrome Drugs Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Short Bowel Syndrome Drugs Sales Forecast by Type (2023-2028)
4.2.2 Global Short Bowel Syndrome Drugs Revenue Forecast by Type (2023-2028)
4.2.3 Short Bowel Syndrome Drugs Price Forecast by Type (2023-2028)
5 Global Short Bowel Syndrome Drugs Market Size by Sale Channel
5.1 Global Short Bowel Syndrome Drugs Historic Market Review by Sale Channel (2017-2022)
5.1.1 Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2022)
5.1.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2017-2022)
5.1.3 Short Bowel Syndrome Drugs Price by Sale Channel (2017-2022)
5.2 Global Short Bowel Syndrome Drugs Market Estimates and Forecasts by Sale Channel (2023-2028)
5.2.1 Global Short Bowel Syndrome Drugs Sales Forecast by Sale Channel (2023-2028)
5.2.2 Global Short Bowel Syndrome Drugs Revenue Forecast by Sale Channel (2023-2028)
5.2.3 Short Bowel Syndrome Drugs Price Forecast by Sale Channel (2023-2028)
6 North America
6.1 North America Short Bowel Syndrome Drugs Sales Breakdown by Company
6.1.1 North America Short Bowel Syndrome Drugs Sales by Company (2017-2022)
6.1.2 North America Short Bowel Syndrome Drugs Revenue by Company (2017-2022)
6.2 North America Short Bowel Syndrome Drugs Market Size by Type
6.2.1 North America Short Bowel Syndrome Drugs Sales by Type (2017-2028)
6.2.2 North America Short Bowel Syndrome Drugs Revenue by Type (2017-2028)
6.3 North America Short Bowel Syndrome Drugs Market Size by Sale Channel
6.3.1 North America Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2028)
6.3.2 North America Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2028)
6.4 North America Short Bowel Syndrome Drugs Market Size by Country
6.4.1 North America Short Bowel Syndrome Drugs Sales by Country (2017-2028)
6.4.2 North America Short Bowel Syndrome Drugs Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Short Bowel Syndrome Drugs Sales Breakdown by Company
7.1.1 Europe Short Bowel Syndrome Drugs Sales by Company (2017-2022)
7.1.2 Europe Short Bowel Syndrome Drugs Revenue by Company (2017-2022)
7.2 Europe Short Bowel Syndrome Drugs Market Size by Type
7.2.1 Europe Short Bowel Syndrome Drugs Sales by Type (2017-2028)
7.2.2 Europe Short Bowel Syndrome Drugs Revenue by Type (2017-2028)
7.3 Europe Short Bowel Syndrome Drugs Market Size by Sale Channel
7.3.1 Europe Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2028)
7.3.2 Europe Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2028)
7.4 Europe Short Bowel Syndrome Drugs Market Size by Country
7.4.1 Europe Short Bowel Syndrome Drugs Sales by Country (2017-2028)
7.4.2 Europe Short Bowel Syndrome Drugs Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Short Bowel Syndrome Drugs Sales Breakdown by Company
8.1.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Company (2017-2022)
8.1.2 Asia Pacific Short Bowel Syndrome Drugs Revenue by Company (2017-2022)
8.2 Asia Pacific Short Bowel Syndrome Drugs Market Size by Type
8.2.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Type (2017-2028)
8.2.2 Asia Pacific Short Bowel Syndrome Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Short Bowel Syndrome Drugs Market Size by Sale Channel
8.3.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2028)
8.3.2 Asia Pacific Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2028)
8.4 Asia Pacific Short Bowel Syndrome Drugs Market Size by Region
8.4.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Region
8.4.2 Asia Pacific Short Bowel Syndrome Drugs Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Short Bowel Syndrome Drugs Sales Breakdown by Company
9.1.1 Latin America Short Bowel Syndrome Drugs Sales by Company (2017-2022)
9.1.2 Latin America Short Bowel Syndrome Drugs Revenue by Company (2017-2022)
9.2 Latin America Short Bowel Syndrome Drugs Market Size by Type
9.2.1 Latin America Short Bowel Syndrome Drugs Sales by Type (2017-2028)
9.2.2 Latin America Short Bowel Syndrome Drugs Revenue by Type (2017-2028)
9.3 Latin America Short Bowel Syndrome Drugs Market Size by Sale Channel
9.3.1 Latin America Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2028)
9.3.2 Latin America Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2028)
9.4 Latin America Short Bowel Syndrome Drugs Market Size by Country
9.4.1 Latin America Short Bowel Syndrome Drugs Sales by Country (2017-2028)
9.4.2 Latin America Short Bowel Syndrome Drugs Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Short Bowel Syndrome Drugs Sales Breakdown by Company
10.1.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Company (2017-2022)
10.1.2 Middle East and Africa Short Bowel Syndrome Drugs Revenue by Company (2017-2022)
10.2 Middle East and Africa Short Bowel Syndrome Drugs Market Size by Type
10.2.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Type (2017-2028)
10.2.2 Middle East and Africa Short Bowel Syndrome Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Short Bowel Syndrome Drugs Market Size by Sale Channel
10.3.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2028)
10.3.2 Middle East and Africa Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2028)
10.4 Middle East and Africa Short Bowel Syndrome Drugs Market Size by Country
10.4.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2017-2028)
10.4.2 Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Emmaus Medical
11.1.1 Emmaus Medical Corporation Information
11.1.2 Emmaus Medical Overview
11.1.3 Emmaus Medical Short Bowel Syndrome Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Emmaus Medical Short Bowel Syndrome Drugs Products and Services
11.1.5 Emmaus Medical Short Bowel Syndrome Drugs SWOT Analysis
11.1.6 Emmaus Medical Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Short Bowel Syndrome Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Merck Short Bowel Syndrome Drugs Products and Services
11.2.5 Merck Short Bowel Syndrome Drugs SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Overview
11.3.3 Takeda Short Bowel Syndrome Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Takeda Short Bowel Syndrome Drugs Products and Services
11.3.5 Takeda Short Bowel Syndrome Drugs SWOT Analysis
11.3.6 Takeda Recent Developments
11.4 Ardelyx
11.4.1 Ardelyx Corporation Information
11.4.2 Ardelyx Overview
11.4.3 Ardelyx Short Bowel Syndrome Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Ardelyx Short Bowel Syndrome Drugs Products and Services
11.4.5 Ardelyx Short Bowel Syndrome Drugs SWOT Analysis
11.4.6 Ardelyx Recent Developments
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Corporation Information
11.5.2 Naia Pharmaceuticals Overview
11.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Products and Services
11.5.5 Naia Pharmaceuticals Short Bowel Syndrome Drugs SWOT Analysis
11.5.6 Naia Pharmaceuticals Recent Developments
11.6 Nutrinia
11.6.1 Nutrinia Corporation Information
11.6.2 Nutrinia Overview
11.6.3 Nutrinia Short Bowel Syndrome Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Nutrinia Short Bowel Syndrome Drugs Products and Services
11.6.5 Nutrinia Short Bowel Syndrome Drugs SWOT Analysis
11.6.6 Nutrinia Recent Developments
11.7 OxThera
11.7.1 OxThera Corporation Information
11.7.2 OxThera Overview
11.7.3 OxThera Short Bowel Syndrome Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 OxThera Short Bowel Syndrome Drugs Products and Services
11.7.5 OxThera Short Bowel Syndrome Drugs SWOT Analysis
11.7.6 OxThera Recent Developments
11.8 GLyPharma Therapeutic
11.8.1 GLyPharma Therapeutic Corporation Information
11.8.2 GLyPharma Therapeutic Overview
11.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Products and Services
11.8.5 GLyPharma Therapeutic Short Bowel Syndrome Drugs SWOT Analysis
11.8.6 GLyPharma Therapeutic Recent Developments
11.9 Sancilio Pharmaceuticals
11.9.1 Sancilio Pharmaceuticals Corporation Information
11.9.2 Sancilio Pharmaceuticals Overview
11.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Products and Services
11.9.5 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs SWOT Analysis
11.9.6 Sancilio Pharmaceuticals Recent Developments
11.10 Zealand Pharma
11.10.1 Zealand Pharma Corporation Information
11.10.2 Zealand Pharma Overview
11.10.3 Zealand Pharma Short Bowel Syndrome Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Zealand Pharma Short Bowel Syndrome Drugs Products and Services
11.10.5 Zealand Pharma Short Bowel Syndrome Drugs SWOT Analysis
11.10.6 Zealand Pharma Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Short Bowel Syndrome Drugs Value Chain Analysis
12.2 Short Bowel Syndrome Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Short Bowel Syndrome Drugs Production Mode & Process
12.4 Short Bowel Syndrome Drugs Sales and Marketing
12.4.1 Short Bowel Syndrome Drugs Sales Channels
12.4.2 Short Bowel Syndrome Drugs Distributors
12.5 Short Bowel Syndrome Drugs Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral Short Bowel Syndrome Drugs
Table 3. Major Manufacturers of Tablet Short Bowel Syndrome Drugs
Table 4. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Short Bowel Syndrome Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Short Bowel Syndrome Drugs Sales by Region (2017-2022) & (K Pcs)
Table 7. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Short Bowel Syndrome Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2017-2022)
Table 10. Global Short Bowel Syndrome Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 11. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Short Bowel Syndrome Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Short Bowel Syndrome Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Short Bowel Syndrome Drugs Market Trends
Table 16. Short Bowel Syndrome Drugs Market Drivers
Table 17. Short Bowel Syndrome Drugs Market Challenges
Table 18. Short Bowel Syndrome Drugs Market Restraints
Table 19. Global Short Bowel Syndrome Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
Table 20. Global Short Bowel Syndrome Drugs Sales Share by Manufacturers (2017-2022)
Table 21. Global Short Bowel Syndrome Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Short Bowel Syndrome Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 23. Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2017-2022)
Table 24. Global Short Bowel Syndrome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Short Bowel Syndrome Drugs as of 2021)
Table 26. Key Manufacturers Short Bowel Syndrome Drugs Average Selling Price (ASP) & (2017-2022) & (USD/Pcs)
Table 27. Key Manufacturers Short Bowel Syndrome Drugs Plants/Factories Distribution
Table 28. Key Manufacturers Short Bowel Syndrome Drugs Area Served
Table 29. Date of Key Manufacturers Enter into Short Bowel Syndrome Drugs Market
Table 30. Key Manufacturers Short Bowel Syndrome Drugs Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Short Bowel Syndrome Drugs Sales (K Pcs) by Type (2017-2022)
Table 33. Global Short Bowel Syndrome Drugs Sales Share by Type (2017-2022)
Table 34. Global Short Bowel Syndrome Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Short Bowel Syndrome Drugs Price (K Pcs) by Type (2017-2022)
Table 36. Global Short Bowel Syndrome Drugs Sales (K Pcs) by Type (2023-2028)
Table 37. Global Short Bowel Syndrome Drugs Sales Share by Type (2023-2028)
Table 38. Global Short Bowel Syndrome Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Short Bowel Syndrome Drugs Revenue Share by Type (2023-2028)
Table 40. Global Short Bowel Syndrome Drugs Price (K Pcs) by Type (2023-2028)
Table 41. Global Short Bowel Syndrome Drugs Sales (K Pcs) by Sale Channel (2017-2022)
Table 42. Global Short Bowel Syndrome Drugs Sales Share by Sale Channel (2017-2022)
Table 43. Global Short Bowel Syndrome Drugs Revenue (US$ Million) Market Share by Sale Channel (2017-2022)
Table 44. Global Short Bowel Syndrome Drugs Price (K Pcs) by Sale Channel (2017-2022)
Table 45. Global Short Bowel Syndrome Drugs Sales (K Pcs) by Sale Channel (2023-2028)
Table 46. Global Short Bowel Syndrome Drugs Sales Share by Sale Channel (2023-2028)
Table 47. Global Short Bowel Syndrome Drugs Revenue (US$ Million) Market Share by Sale Channel (2023-2028)
Table 48. Global Short Bowel Syndrome Drugs Revenue Share by Sale Channel (2023-2028)
Table 49. Global Short Bowel Syndrome Drugs Price (K Pcs) by Sale Channel (2023-2028)
Table 50. North America Short Bowel Syndrome Drugs Sales by Company (2017-2022) & (K Pcs)
Table 51. North America Short Bowel Syndrome Drugs Sales Market Share by Company (2017-2022)
Table 52. North America Short Bowel Syndrome Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Short Bowel Syndrome Drugs Revenue Market Share by Company (2017-2022)
Table 54. North America Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)
Table 55. North America Short Bowel Syndrome Drugs Sales by Type (2023-2028) & (K Pcs)
Table 56. North America Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Short Bowel Syndrome Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 59. North America Short Bowel Syndrome Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 60. North America Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 61. North America Short Bowel Syndrome Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 62. North America Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)
Table 63. North America Short Bowel Syndrome Drugs Sales by Country (2023-2028) & (K Pcs)
Table 64. North America Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Short Bowel Syndrome Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Short Bowel Syndrome Drugs Sales by Company (2017-2022) & (K Pcs)
Table 67. Europe Short Bowel Syndrome Drugs Sales Market Share by Company (2017-2022)
Table 68. Europe Short Bowel Syndrome Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Short Bowel Syndrome Drugs Revenue Market Share by Company (2017-2022)
Table 70. Europe Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)
Table 71. Europe Short Bowel Syndrome Drugs Sales by Type (2023-2028) & (K Pcs)
Table 72. Europe Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Short Bowel Syndrome Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 75. Europe Short Bowel Syndrome Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 76. Europe Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 77. Europe Short Bowel Syndrome Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 78. Europe Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)
Table 79. Europe Short Bowel Syndrome Drugs Sales by Country (2023-2028) & (K Pcs)
Table 80. Europe Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Short Bowel Syndrome Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Short Bowel Syndrome Drugs Sales by Company (2017-2022) & (K Pcs)
Table 83. Asia Pacific Short Bowel Syndrome Drugs Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Short Bowel Syndrome Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Short Bowel Syndrome Drugs Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)
Table 87. Asia Pacific Short Bowel Syndrome Drugs Sales by Type (2023-2028) & (K Pcs)
Table 88. Asia Pacific Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Short Bowel Syndrome Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 91. Asia Pacific Short Bowel Syndrome Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 92. Asia Pacific Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 93. Asia Pacific Short Bowel Syndrome Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 94. Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2017-2022) & (K Pcs)
Table 95. Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2023-2028) & (K Pcs)
Table 96. Asia Pacific Short Bowel Syndrome Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Short Bowel Syndrome Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Short Bowel Syndrome Drugs Sales by Company (2017-2022) & (K Pcs)
Table 99. Latin America Short Bowel Syndrome Drugs Sales Market Share by Company (2017-2022)
Table 100. Latin America Short Bowel Syndrome Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Short Bowel Syndrome Drugs Revenue Market Share by Company (2017-2022)
Table 102. Latin America Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)
Table 103. Latin America Short Bowel Syndrome Drugs Sales by Type (2023-2028) & (K Pcs)
Table 104. Latin America Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Short Bowel Syndrome Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 107. Latin America Short Bowel Syndrome Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 108. Latin America Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 109. Latin America Short Bowel Syndrome Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 110. Latin America Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)
Table 111. Latin America Short Bowel Syndrome Drugs Sales by Country (2023-2028) & (K Pcs)
Table 112. Latin America Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Short Bowel Syndrome Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Short Bowel Syndrome Drugs Sales by Company (2017-2022) & (K Pcs)
Table 115. Middle East and Africa Short Bowel Syndrome Drugs Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Short Bowel Syndrome Drugs Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)
Table 119. Middle East and Africa Short Bowel Syndrome Drugs Sales by Type (2023-2028) & (K Pcs)
Table 120. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 123. Middle East and Africa Short Bowel Syndrome Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 124. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)
Table 127. Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2023-2028) & (K Pcs)
Table 128. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 130. Emmaus Medical Corporation Information
Table 131. Emmaus Medical Description and Overview
Table 132. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 133. Emmaus Medical Short Bowel Syndrome Drugs Product and Services
Table 134. Emmaus Medical Short Bowel Syndrome Drugs SWOT Analysis
Table 135. Emmaus Medical Recent Developments
Table 136. Merck Corporation Information
Table 137. Merck Description and Overview
Table 138. Merck Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 139. Merck Short Bowel Syndrome Drugs Product and Services
Table 140. Merck Short Bowel Syndrome Drugs SWOT Analysis
Table 141. Merck Recent Developments
Table 142. Takeda Corporation Information
Table 143. Takeda Description and Overview
Table 144. Takeda Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 145. Takeda Short Bowel Syndrome Drugs Product and Services
Table 146. Takeda Short Bowel Syndrome Drugs SWOT Analysis
Table 147. Takeda Recent Developments
Table 148. Ardelyx Corporation Information
Table 149. Ardelyx Description and Overview
Table 150. Ardelyx Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 151. Ardelyx Short Bowel Syndrome Drugs Product and Services
Table 152. Ardelyx Short Bowel Syndrome Drugs SWOT Analysis
Table 153. Ardelyx Recent Developments
Table 154. Naia Pharmaceuticals Corporation Information
Table 155. Naia Pharmaceuticals Description and Overview
Table 156. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 157. Naia Pharmaceuticals Short Bowel Syndrome Drugs Product and Services
Table 158. Naia Pharmaceuticals Short Bowel Syndrome Drugs SWOT Analysis
Table 159. Naia Pharmaceuticals Recent Developments
Table 160. Nutrinia Corporation Information
Table 161. Nutrinia Description and Overview
Table 162. Nutrinia Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 163. Nutrinia Short Bowel Syndrome Drugs Product and Services
Table 164. Nutrinia Short Bowel Syndrome Drugs SWOT Analysis
Table 165. Nutrinia Recent Developments
Table 166. OxThera Corporation Information
Table 167. OxThera Description and Overview
Table 168. OxThera Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 169. OxThera Short Bowel Syndrome Drugs Product and Services
Table 170. OxThera Short Bowel Syndrome Drugs SWOT Analysis
Table 171. OxThera Recent Developments
Table 172. GLyPharma Therapeutic Corporation Information
Table 173. GLyPharma Therapeutic Description and Overview
Table 174. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 175. GLyPharma Therapeutic Short Bowel Syndrome Drugs Product and Services
Table 176. GLyPharma Therapeutic Short Bowel Syndrome Drugs SWOT Analysis
Table 177. GLyPharma Therapeutic Recent Developments
Table 178. Sancilio Pharmaceuticals Corporation Information
Table 179. Sancilio Pharmaceuticals Description and Overview
Table 180. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 181. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product and Services
Table 182. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs SWOT Analysis
Table 183. Sancilio Pharmaceuticals Recent Developments
Table 184. Zealand Pharma Corporation Information
Table 185. Zealand Pharma Description and Overview
Table 186. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 187. Zealand Pharma Short Bowel Syndrome Drugs Product and Services
Table 188. Zealand Pharma Short Bowel Syndrome Drugs SWOT Analysis
Table 189. Zealand Pharma Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Short Bowel Syndrome Drugs Distributors List
Table 193. Short Bowel Syndrome Drugs Customers List
Table 194. Research Programs/Design for This Report
Ta

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs